-transparent.png){kind=logo}
Chimeric antigen receptor-T cell therapies: The changing landscape. 2022
Section of Hematology and Stem Cell Transplant Vanderbilt Ingram Cancer Center Department of Medicine Vanderbilt University Medical Center Nashville Tennessee USA.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Salyka M Sengsayadeth, and
Bhagirathbhai R Dholaria, and
Bipin N Savani, and
Olalekan O Oluwole
November 2016,
Journal of the National Cancer Institute,
Salyka M Sengsayadeth, and
Bhagirathbhai R Dholaria, and
Bipin N Savani, and
Olalekan O Oluwole
January 2018,
Nature reviews. Clinical oncology,
Salyka M Sengsayadeth, and
Bhagirathbhai R Dholaria, and
Bipin N Savani, and
Olalekan O Oluwole
March 2018,
Nature reviews. Drug discovery,
Salyka M Sengsayadeth, and
Bhagirathbhai R Dholaria, and
Bipin N Savani, and
Olalekan O Oluwole
September 2020,
British journal of clinical pharmacology,
Salyka M Sengsayadeth, and
Bhagirathbhai R Dholaria, and
Bipin N Savani, and
Olalekan O Oluwole
November 2019,
Journal of hematology & oncology,
Salyka M Sengsayadeth, and
Bhagirathbhai R Dholaria, and
Bipin N Savani, and
Olalekan O Oluwole
December 2017,
Blood,
Salyka M Sengsayadeth, and
Bhagirathbhai R Dholaria, and
Bipin N Savani, and
Olalekan O Oluwole
December 2020,
Nature biotechnology,
Salyka M Sengsayadeth, and
Bhagirathbhai R Dholaria, and
Bipin N Savani, and
Olalekan O Oluwole
December 2021,
Trends in biotechnology,
Salyka M Sengsayadeth, and
Bhagirathbhai R Dholaria, and
Bipin N Savani, and
Olalekan O Oluwole
December 2020,
Frontiers of medicine,
Salyka M Sengsayadeth, and
Bhagirathbhai R Dholaria, and
Bipin N Savani, and
Olalekan O Oluwole
June 2017,
Cytotherapy,
